Pricing Log in Create free account

enGene Therapeutics Inc (ENGN) vs Nkarta, Inc. (NKTX)

enGene Therapeutics Inc and Nkarta, Inc. are both Biotechnology companies. enGene Therapeutics Inc and Nkarta, Inc. are of similar size ($112.6M and $112.5M). Across the 11 metrics below, Nkarta, Inc. leads on 8 and enGene Therapeutics Inc on 3.

Valuation

Metric ENGN NKTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.53 0.53 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.86 0.42 0.66
EV/Sales n/m n/m 9.02
Earnings yield (117.61%) (89.71%) (32.88%)
Free cash flow yield (84.73%) (72.03%) (23.13%)

Profitability

Metric ENGN NKTX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (60.50%) (38.76%) (51.96%)
Return on assets (48.84%) (29.86%) (46.06%)
Return on invested capital 0.00% (127.22%) 0.00%

Growth

Metric ENGN NKTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (56.85%) 11.88% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENGN NKTX Biotechnology median
Debt to equity 0.11 0.00 0.00
Current ratio 10.21 7.98 4.97
Net debt to EBITDA 1.42 2.35 1.01

Dividend

Metric ENGN NKTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENGN NKTX Biotechnology median
Market cap 112.59m 112.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack